Clinical Trials Browser

Phase 1 × Pancreatic Neoplasms × BI 2536 × Clear all

NCT02215044 2014-08-13

Dose-finding Study of BI 2536 Administered in Combination With Gemcitabine in Patients With Locally Advanced or Metastatic Pancreatic Cancer

Phase 1 Terminated

Gastrointestinal

Pancreatic Neoplasms